Why does everybody hate biotech shares? Can Large Science create an precise enterprise? And what are Martin Shkreli’s job prospects?
We cowl all that and extra this week on “The Readout LOUD,” STAT’s biotech podcast. With biotech within the dumps, we discuss to Oppenheimer analyst Jared Holz about why the world has soured on the sector and what it means for the way forward for drugs. Then, STAT’s Matthew Herper joins us to elucidate the newest massive thought from biotech’s massive thinkers: an organization referred to as Altos Labs, which has raised $3 billion to do one thing or different. We additionally focus on the newest information within the life sciences, with a cameo from Shkreli and an replace on Omicron.
For extra on what we cowl, right here’s the news on Altos; right here’s the latest on pandemic trends; right here’s more on the hurdles to getting Covid-19 antivirals; right here’s where you can subscribe to the First Opinion Podcast; and right here’s our complete coverage of the Covid-19 pandemic.
And if in case you have any suggestions for us — matters to cowl, company to ask, vocal tics to stop — you possibly can e-mail [email protected].
Fascinated with sponsoring a future episode of “The Readout LOUD”? Electronic mail us at [email protected].